Have a feature idea you'd love to see implemented? Let us know!

ARCT Arcturus Therapeutics Holdings PE ratio, current and historical analysis

The current PE ratio of ARCT can't be determined, as the TTM EPS of -$2.34 is negative. The last PE ratio of Arcturus Therapeutics Holdings, recorded in September 2023, was 6.8.

ARCT PE ratio history

How has ARCT's PE ratio performed in the past

Average

N/A

Median

N/A

Minimum

N/A

Maximum

N/A

Arcturus Therapeutics Holdings PE ratio by year

Year	PE ratio	Change
2023	N/A	N/A
2022	48.46	N/A
2021	N/A	N/A
2020	N/A	N/A
2019	N/A	N/A
2018	N/A	N/A
2017	N/A	N/A
2016	N/A	N/A
2015	N/A	N/A
2014	N/A	N/A

ARCT average PE ratio chart

What is the average PE ratio of ARCT for the past years

3-year avg

N/A

5-year avg

N/A

10-year avg

N/A

15-year avg

N/A

ARCT PE vs peers

What is ARCT's PE ratio compared to its peers

Stock name	PE ratio	Market cap
OMIC Singular Genomics Systems Inc	N/A	$53.8M
NWBO Northwest Biotherapeutics Inc	N/A	$352.26M
ARCT Arcturus Therapeutics Holdings Inc	N/A	$458.05M

Frequently asked questions

What is Arcturus Therapeutics Holdings's PE ratio?

The current price to earnings ratio of ARCT can't be calculated, as its EPS of -$2.34 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.